Search

Reset

Searching with a thematic focus on Health, HIV and AIDS, HIV and AIDS treatment and care

Showing 171-180 of 446 results

Pages

  • Document

    Equity in health sector responses to HIV/AIDS in Malawi

    EQUINET: Network for Equity in Health in Southern Africa, 2003
    In Malawi, HIV/AIDS has created an increasing demand for healthcare, exacerbated by population pressure, chronic poverty and food insecurity. This demand is set against a reduced capacity to supply healthcare.
  • Document

    Intellectual property rights, anti-AIDS policy and generic drugs: lessons from the Brazilian public health program

    International AIDS Economics Network, 2003
    The paper analyses Brazil’s national anti-Aids programme. The focus is on the main choices that have governed the Programme’s preparation, the obstacles it has faced and how it has overcome them.
  • Document

    Setting priorities for government involvement with antiretrovirals

    International AIDS Economics Network, 1997
    This paper examines four questions posed by economic analysis to help set priorities for government involvement with antiretroviral therapy for people living with HIV/AIDS. The main focus is on making decisions about policy relating to ARVs in developing countries where the needs are greatest and resource constraints are most binding.
  • Document

    Antiretroviral treatment can be cost-saving for industry and life-saving for workers: a case study from Côte d’Ivoire’s private sector

    International AIDS Economics Network, 2003
    This paper aims to describe the health and economic impact of comprehensive HIV care with Anti-Retroviral Treatments (ART) within a private enterprise in Côte d’Ivoire.It describes how an “HIV solidarity fund” is used to finance ART to HIV-infected workers in Côte d’Ivoire.
  • Document

    Drugs in development: new promise [ACRIA Update, vol 12]

    AIDS Community Research Initiative of America, 2003
    This issue of ACRIA Update focuses on antiretrovirals that are being developed to deal with problems of new formulations of old drugs, second generation drugs in existing classes, drugs like entry inhibitors that target HIV at different points in its life cycle, and drugs that are in very early stages of development.The paper demonstrates that we may never hear of some of these drugs again; the
  • Document

    The cost of treating HIV/AIDS with ARVs in South Africa: Who knows? Who cares?

    International AIDS Economics Network, 2002
    This paper reports on a survey conducted of completed studies and research in progress produced by public, private and non-government institutions that have estimated and documented the cost of treatment of HIV/AIDS with ARVs in South Africa.
  • Document

    Feeding indecision: choosing to breastfeed in the era of HIV

    id21 Development Research Reporting Service, 2002
    Women in low and middle income countries who know they have HIV face a difficult choice. Should they breastfeed and risk passing on the virus to their child? Or not breastfeed and accept the cost and stigma associated with using breast milk substitutes (BMS)? Researchers from the Liverpool School of Tropical Medicine and UTH, Lusaka investigated mothers’ choices in Lusaka, Zambia.
  • Document

    The potential demand for and strategic use of an HIV-1 vaccine in Southern India

    World Bank, 2003
    This paper assesses the potential demand for and strategic use of an HIV- 1 vaccine in southern India. It assesses the size of potential high- and low-risk target groups for an HIV-1 vaccine in the 117 districts of Andhra Pradesh, Maharasthra, Karnataka, and Tamil Nadu.
  • Document

    Dangerous liaisons: people in cross-generational relationships underestimate risk

    Population Services International, 2003
    This paper presents a study of Kenyan women’s and men’s motivations for entering into cross-generational relationships and their risk perceptions of such relationships. Eight focus groups were conducted with women aged 15-19 and 28 in-depth interviews were carried out with men aged 30 years and older in Nairobi, Mombassa, Kisumu and Meru.
  • Document

    Guidelines for implementing collaborative TB and HIV programme activities

    World Health Organization, 2003
    These World Health Organization guidelines aim to enable national tuberculosis (TB) and HIV/AIDS programmes to support districts in the planning, coordination and implementation of collaborative TB/HIV activities. They are intended for countries with either an overlapping TB and HIV epidemic or where there is an increasing HIV rate which may fuel the TB epidemic.

Pages